Business

January 2, 2014 1:02 PM

Salix completes acquisition of Santarus

Salix Pharmaceuticals reported Thursday that it has completed its $2.6 billion acquisition of the specialty drug company Santarus.

Related content

Comments

Videos

Today's Market

Nasdaq
Powered by Barchart

Editor's Choice Videos

Raleigh Top Jobs

View All Top Jobs